EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Class Action Claims Against Vascular Solutions, Inc.

The Rosen Law Firm announces that it is investigating potential securities claims against Vascular Solutions, Inc. (NASDAQ:VASC) resulting from allegations that the Company may have issued materially misleading business information to the investing public.

On November 13, 2014, a federal grand jury indicted Vascular Solutions’ CEO, Howard Root, on charges he conspired to sell a varicose-vein treatment device for unapproved uses. The nine count indictment alleges the Company improperly marketed its Vari-Lase device kit for use on veins deep in the leg, even though it was only approved for use on superficial blood vessels and a clinical trial showed adverse events when Vari-Lase was used on deeper veins. On this news, shares of Vascular Solutions fell sharply during intraday trading on November 14, 2014, damaging investors.

The Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Vascular Solutions shareholders as a result of this adverse information. If you purchased Vascular Solutions stock on or before November 13, 2014, and want to recover your losses, you can join the class action at http://rosenlegal.com/cases-440.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.